Seeking Alpha

Covidien (COV +2.4%) gains after its FQ4 EPS easily beat estimates. Earnings rose 1.8% Y/Y,...

Covidien (COV +2.4%) gains after its FQ4 EPS easily beat estimates. Earnings rose 1.8% Y/Y, fueled by growth in its medical-devices business and an extra week of sales that boosted revenue by 7% - 8% during the period. The company also boosts FY12 sales guidance to an increase of around 3% - 5% due to positive FX rates.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)